Genomics Market is expected to grow at a CAGR of 23% from 2022 to 2032

According to Future Market Insights’ newly released Genomics industry analysis report, According to Future Market Insights’ recently published analysis of the genomics market, global sales of genomics were estimated to reach $24.3 billion in 2021. The anticipated market growth from 2022 to 2032 is anticipated to be 19.8%, which will be much larger than the increase …

Vitrectomy Devices Market is projected to US$ 2.6 billion by 2032

According to Future Market Insights’ newly released Vitrectomy Devices Market analysis report, According to a recently published industry study report by Future Market Insights, sales of vitrectomies devices were US$ 1.2 billion worldwide in 2021. The market is anticipated to grow at a CAGR of 7.3% from 2022 to 2032, reaching a worth of US$ 2.6 billion. The greatest …

Synthetic Biology Market is expected to reach US$ 138.8 Billion by 2032 to register a 24.3% CAGR

The global Synthetic Biology Market is expected to be worth US$ 15.8 billion by the end of 2022, and to grow at a CAGR of 24.3% to be worth US$ 138.8 billion by 2032. According to a recent study by Future Market Insights, the oligonucleotides segment by product will lead the market with a share of approximately …

Demand for Peripheral Vascular Devices Market in Europe is expected to register a 6.2% CAGR from 2022 to 2032

The global Peripheral Vascular Devices Market is expected to enjoy a valuation of US$ 4.7 Bn by the end of the year 2022, and further expand at a CAGR of 6.6% to reach a valuation of ~US$ 8.9 Bn by the year 2032. According to a recent study by Future Market Insights, peripheral vascular stents are leading the market with a share of …

Insulin Biosimilars Market | Eli Lilly & Co., Boehringer Ingelheim, Merck & Co., Pfizer Inc. | By 2032

The demand for Insulin Biosimilars Market is expected to reach US$ 1,468.6 million in 2022, rising at a CAGR of 14.9% to US$ 5,876.4 million from 2022 to 2032. Globally rising diabetic patient numbers are blamed for growth. A CAGR of 21.5% was recorded for the market for insulin biosimilars from 2016 to 2021. Biosimilar …

Glaucoma Therapeutics Market is projected to reach US$ 10.2 Million by 2032 at a CAGR of 3.7%

The Glaucoma Therapeutics Market is anticipated to reach US$ 6.9 million in 2022. Between 2022 and 2032, the worldwide demand for glaucoma therapies is predicted to increase at a CAGR of 3.7%, reaching over US$ 10.2 million by that time. Glaucoma Therapeutics Market is expected show exponential growth over the forecast period due to increasing prevalence …

Cloud Based Drug Discovery Platform Market is projected to reach US$ 7,529.59 Million by 2032 at a CAGR of 12.6%

The Cloud Based Drug Discovery Platform Market is anticipated to grow at a rapid CAGR of 12.6% over the course of the forecast period. In 2022, the market will be worth US$ 2,424.33 Million. By the year 2032, it is predicted that the market for cloud-based drug discovery platforms would reach a high of US$ …

Plasma Separation Tubes Market is expected to reach a valuation of US$ 874.6 Million at a CAGR of 6.5% by 2031 | FMI

According to a Future Market Insights (FMI) study, the Plasma Separation Tubes Market will generate US$ 466.6 million in revenue in 2021. Plasma separation tube sales as a whole are anticipated to total US$ 874.6 Million by 2031, growing at a CAGR of 6.5% between 2021 and 2031. Antigens, antibodies, and foreign nucleic acid present …

Geriatric Population to sweep the Glaucoma Treatment Market, reaching US$ 8 Billion at a CAGR of 3.2% by 2033 | FMI

The global Glaucoma Treatment Market holds a valuation of US$ 5.7 Billion by the end of the year 2022. During the forecast period of 2023 to 2033, the market is expected to grow at a CAGR of 3.2%, with a market value of around US$ 8.0 billion in 2033. The elderly population is more into …

Transcatheter Heart Valve Replacement (TAVR) Market is projected to grow at a CAGR of 14.8% between 2023 and 2033

The global Transcatheter Heart Valve Replacement (TAVR) Market is valued at US$ 5.7 billion in 2022, and it is expected to grow at a 14.8% CAGR over the forecasted years. According to a recent Future Market Insights study, balloon-expandable transcatheter aortic valves will command a market share of approximately 52.5% in 2022. The report focuses …